Effect of macrophages on biological function of ovarian cancer cells in tumor microenvironment in vitro

Jiang Yi,Yuan Lin,Wan Yicong,Luo Chengyan,Zhou Shulin,Cheng Wenjun

DOI: https://doi.org/10.1007/s00404-020-05719-8

2020-08-03

Archives of Gynecology and Obstetrics

Abstract:To investigate the influence of two types of tumor-associated macrophages (TAMs) on the biological function of human ovarian cell lines in vitro.

obstetrics & gynecology

What problem does this paper attempt to address?

Ott_a_216355 8687..8699

Meichen Yin,Jiayu Shen,Shuqian Yu,Jing Fei,Xiao-qing Zhu,Jiayao Zhao,Ling-Yun Zhai,Annapurna Sadhukhan,Jian-wei Zhou

2019-01-01

Abstract:Department of Gynecology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China Abstract: Tumor-associated macrophages (TAMs) that appear in every stage of cancer progression are usually tumor-promoting cells and are present abundantly in the tumorassociated microenvironment. In ovarian cancer, the overall and intratumoral M1/M2 ratio is a relatively efficient TAM parameter for predicting the prognosis of patients, especially for serous tissue type cancer. TAMs exhibit immunological checkpoint modulators, such as the B7 family and programmed death-ligand 1 (PD-L1), and play a key role in the development, metastasis and invasion of ovarian cancer, but the underlying mechanism is barely understood. Ovarian cancer is a severe gynecological malignancy with high mortality. Ovarian cancer-associated death can primarily be attributed to cancer metastasis. The majority of patients are diagnosed with wide dissemination in the peritoneum and omentum, limiting the effectiveness of surgery and chemotherapy. In addition, unlike other well-documented cancers, metastasis through vasculature is not a usual dissemination pathway in ovarian cancer. This review sheds light on TAMs and the main process and mechanism of ovarian cancer metastasis.
Tumor-Associated Macrophages in Tumor Immunity (vol 11, 583084, 2020)

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:Tumor-associated macrophages (TAMs) represent one of the main tumor-infiltrating immune cell types and are generally categorized into either of two functionally contrasting subtypes, namely classical activated M1 macrophages and alternatively activated M2 macrophages. The former typically exerts anti-tumor functions, including directly mediate cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC) to kill tumor cells; the latter can promote the occurrence and metastasis of tumor cells, inhibit T cell-mediated anti-tumor immune response, promote tumor angiogenesis, and lead to tumor progression. Both M1 and M2 macrophages have high degree of plasticity and thus can be converted into each other upon tumor microenvironment changes or therapeutic interventions. As the relationship between TAMs and malignant tumors becoming clearer, TAMs have become a promising target for developing new cancer treatment. In this review, we summarize the origin and types of TAMs, TAMs interaction with tumors and tumor microenvironment, and up-to-date treatment strategies targeting TAMs.
Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction

Amr Ahmed El-Arabey,Samia S. Alkhalil,Samia T. Al-Shouli,Maaweya E. Awadalla,Heba W. Alhamdi,Taghreed N. Almanaa,Samah Saif Eldin M. Mohamed,Mohnad Abdalla

DOI: https://doi.org/10.1007/s12032-023-01987-x

2023-04-12

Medical Oncology

Abstract:Tumor-associated macrophages (TAMs) are an important component of the tumor microenvironment (TME) and have been linked to immunosuppression and poor prognosis. TAMs have been shown to be harmful in ovarian cancer (OC), with a positive correlation between their high levels of tumors and poor overall patient survival. These cells are crucial in the progression and chemoresistance of OC. The primary pro-tumoral role of TAMs is the release of cytokines, chemokines, enzymes, and exosomes that directly enhance the invasion potential and chemoresistance of OC by activating their pro-survival signalling pathways. TAMs play a crucial role in the metastasis of OC in the peritoneum and ascities by assisting in spheroid formation and cancer cell adhesion to the metastatic regions. Furthermore, TAMs interact with tumor protein p53 (TP53), exosomes, and other immune cells, such as stem cells and cancer-associated fibroblasts (CAFs) to support the progression and metastasis of OC. In this review we revisit development, functions and interactions of TAMs in the TME of OC patients to highlight and shed light on challenges and excitement down the road.

oncology
Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients

Yang Gao,Yuwen Qi,Yin Shen,Yaxing Zhang,Dandan Wang,Min Su,Xuelian Liu,Anjin Wang,Wenwen Zhang,Can He,Junyuan Yang,Mengyuan Dai,Hua Wang,Hongbing Cai

DOI: https://doi.org/10.18632/aging.205362

2024-01-05

Aging

Abstract:Ovarian cancer (OC) ranks as the second leading cause of death among gynecological cancers. Numerous studies have indicated a correlation between the tumor microenvironment (TME) and the clinical response to treatment in OC patients. Tumor-associated macrophages (TAMs), a crucial component of the TME, exert influence on invasion, metastasis, and recurrence in OC patients. To delve deeper into the role of TAMs in OC, this study conducted an extensive analysis of single-cell data from OC patients....

cell biology,geriatrics & gerontology,gerontology
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy

David Schweer,Annabel McAtee,Khaga Neupane,Christopher Richards,Frederick Ueland,Jill Kolesar

DOI: https://doi.org/10.3390/cancers14092220

2022-04-29

Cancers

Abstract:The tumor microenvironment (TME) has been implicated to play an important role in the progression of ovarian cancer. One of the most important components of the TME is tumor associated macrophages (TAMs). Phenotypically, macrophages are broadly categorized as M1 pro-inflammatory or M2 anti-inflammatory, based on the cytokines and chemokines that they secrete. The tumor microenvironment is associated with macrophages of an M2 phenotype which suppress the surrounding immune environment, assist tumor cells in evading immune targeting, and support tumor growth and metastasis. Contrarily, M1 macrophages help mount an immune response against tumors, and are associated with a more favorable prognosis in solid tumors. One of the characteristic indicators of a poor prognosis in ovarian cancer is the overrepresentation of M2-type TAMs. As such, therapeutic modalities targeting TME and TAMs are of increasing interest. Pharmacological approaches to eliminate TAMs, include decreasing macrophage survival and recruitment and increasing phagocytosis, have been underwhelming. Clinical strategies targeting these macrophage subtypes via repolarization to an M1 antitumoral state deserve increasing attention, and may serve as a new modality for immunotherapy.

oncology
[Effect of Antibacterial Peptide Hcap18/ll-37 on Ovarian Cancer Microenvironment and the Regulatory Mechanism of Its Expression].

Qian Lu,Wenqiang Quan,Junlu Wu,Xian Zhang,Wei Ma,Li Pang,Dong Li

DOI: https://doi.org/10.3760/cma.j.issn.0253-3766.2015.10.002

2015-01-01

Abstract:OBJECTIVE:To investigate the effect of antibacterial peptide hCAP18/LL-37 on ovarian cancer microenvironment and the regulatory mechanism of its expression.METHODS:We assessed the effect of macrophage-promoted ovarian cancer cells invasion using BioCoat Matrigel invasion chamber. The expressions of hCAP18/LL-37 and versican V1 were determined by real-time PCR and Western blot analysis. SKOV3 cells were transfected with shRNA plasmid to abrogate the expression of versican V1, and then the expression of hCAP18/LL-37 in macrophages and the invasiveness of SKOV3 cells were assayed.RESULTS:The Matrigel invasion assay showed that after co-culture with macrophages for 4 days, the number of penetrated SKOV3 cells was 112.8±17.1/per high power field, significantly higher than that in the SKOV3 cells cultured alone (8.2±1.9/per high power field) (P<0.05). Addition of hCAP/LL-37 neutralizing antibody into the co-cultured macrophage-SKOV3 cells markedly inhibited the macrophage-promoted SKOV3 cells invasion. The penetrated SKOV3 cells was 22.2±5.6/per high power field, significantly lower than the 100.6±25.2/per high power field in the control macrophage- SKOV3 co-cultured cells (P<0.05). The expressions of hCAP18/LL-37 mRNA and protein in macrophages were remarkably enhanced upon co-culture with SKOV3 cells, but not changed in SKOV3 cells cultured alone. The expression and secretion of versican V1 in the ovarian cancer cells were also significantly increased after co-cultured with macrophages. Knockdown of versican V1 in SKOV3 cells by small interfering RNA significantly reduced the expression of hCAP18/LL-37 mRNA and protein in the macrophages, as well as decreased the invasiveness of SKOV3 cells (P<0.05).CONCLUSIONS:In the cancer microenvironment, the macrophage-secreted hCAP18/LL-37 promote the invasiveness of ovarian cancer cells, and the hCAP18/LL-37 expression is regulated by versican V1 protein released by ovarian cancer cells.
Tumor-Associated Macrophages (tams): A Critical Activator in Ovarian Cancer Metastasis

Meichen Yin,Jiayu Shen,Shuqian Yu,Jing Fei,Xiaoqing Zhu,Jiayao Zhao,Lingyun Zhai,Annapurna Sadhukhan,Jianwei Zhou

DOI: https://doi.org/10.2147/ott.s216355

IF: 4

2019-01-01

OncoTargets and Therapy

Abstract:Tumor-associated macrophages (TAMs) that appear in every stage of cancer progression are usually tumor-promoting cells and are present abundantly in the tumor-associated microenvironment. In ovarian cancer, the overall and intratumoral M1/M2 ratio is a relatively efficient TAM parameter for predicting the prognosis of patients, especially for serous tissue type cancer. TAMs exhibit immunological checkpoint modulators, such as the B7 family and programmed death-ligand 1 (PD-L1), and play a key role in the development, metastasis and invasion of ovarian cancer, but the underlying mechanism is barely understood. Ovarian cancer is a severe gynecological malignancy with high mortality. Ovarian cancer-associated death can primarily be attributed to cancer metastasis. The majority of patients are diagnosed with wide dissemination in the peritoneum and omentum, limiting the effectiveness of surgery and chemotherapy. In addition, unlike other well-documented cancers, metastasis through vasculature is not a usual dissemination pathway in ovarian cancer. This review sheds light on TAMs and the main process and mechanism of ovarian cancer metastasis.
Prognostic Significance of Tumor-Associated Macrophages in Ovarian Cancer: A Meta-Analysis.

Xia Yuan,Jing Zhang,Dan Li,Mao Ye,Fei Mo,Wei Du,Xuelei Ma

DOI: https://doi.org/10.1016/j.ygyno.2017.07.007

IF: 5.304

2017-01-01

Gynecologic Oncology

Abstract:Objective The role of tumor-associated macrophages (TAMs) in tumor microenvironment remains controversial due to the two different polarized subsets of TAMs. Here, we performed a meta-analysis to evaluate the correlation between subpopulations of TAMs and clinical outcomes in patients with ovarian cancer. Methods A comprehensive search in PUBMED/Medline and EMBASE databases was performed. The association between TAMs and patient prognosis of ovarian cancer was estimated with hazard ratios (HRs) and their corresponding 95% confidence intervals (95% CIs) using a random-effect model. Additionally, sensitivity analysis and Begg's test were conducted. Results Nine studies including 794 patients were enrolled in the meta-analysis. The results showed that higher M1/M2 ratio in tumor tissues was associated with a favorable overall survival (OS) (HR = 0.449, 95% CI = 0.283–0.712, P = 0.001). Elevated intra-islet M1/M2 TAMs ratio showed a positive correlation for OS (HR = 0.510, 95% CI = 0.264–0.986, P = 0.045). No significant relation was observed between OS and CD68+ TAMs (HR = 0.99, 95% CI = 0.88–1.11, P = 0.859), CD163+ TAMs (HR = 1.04, 95% CI = 0.92–1.16, P = 0.544) or CD163+/CD68+ TAMs ratio (HR = 1.628, 95% CI = 0.529–5.008, P = 0.395). Worse progression-free survival (PFS) was associated with high density of CD163+ TAMs (HR = 2.157, 95% CI = 1.406–3.312, P = 0.000) and higher ratio of CD163+/CD68+ TAMs (HR = 3.223, 95% CI = 1.805–5.755, P = 0.000). Elevated M1/M2 TAMs ratio predicted better PFS of ovarian cancer (HR = 0.490, 95% CI = 0.270–0.890, P = 0.019). Furthermore, high density of CD163+ and CD68+ TAMs was observed in ovarian cancer with advanced TNM stage. Conclusion In our study, it was revealed that CD163+ TAMs infiltration was associated with poor prognosis of ovarian cancer and high M1/M2 macrophages ratio in tumor tissues predicted better prognosis.
Integrated immunogenomic analysis of single-cell and bulk tissue transcriptome profiling unravels a macrophage activation paradigm associated with immunologically and clinically distinct behaviors in ovarian cancer

Congcong Yan,Ke Li,Fanling Meng,Lu Chen,Jingting Zhao,Zicheng Zhang,Dandan Xu,Jie Sun,Meng Zhou

DOI: https://doi.org/10.1016/j.jare.2022.04.006

IF: 12.822

2022-04-01

Journal of Advanced Research

Abstract:Highlights•Integrated immunogenomic analysis of single-cell and bulk tissue transcriptome profiling was conducted.•Two novel OV subgroups were characterized by a balance between M0, M1 and M2 macrophages with distinct clinical and immunological behaviors.•A macrophage polarization-derived artificial neural network model (MacroANN) was developed to predict patient outcomes and therapeutic efficacy.IntroductionIncreasing evidence demonstrates that the activation states and diverse spectrum of macrophage subtypes display dynamic heterogeneity in the tumor microenvironment, which plays a critical role in a variety of cancer types.ObjectivesTo investigate the heterogeneity and the homeostasis of different macrophage subtypes, as well as their effect on biological and clinical manifestations of ovarian cancer (OV).MethodIntegrated immunogenomic analysis of single-cell and bulk tissue transcriptome profiling was performed to systematically investigate the association between macrophage activation and prognostic and therapeutic efficacy. Consensus clustering analysis was used to define novel macrophage subtypes. An artificial neural network was used to simulate the dynamic activation of macrophages.ResultsThe pan-cohort results suggested that high relative infiltration abundance of M0 and M1 macrophages was associated with improved outcome and therapeutic efficacy. By contrast, the oppositive was true for M2 macrophages. Unsupervised consensus clustering analysis revealed two OV subgroups characterized by a balance between M0, M1 and M2 macrophages with distinct clinical and immunological behaviors. Finally, a macrophage polarization-derived artificial neural network model was proposed to serve as a robust prognostic factor and predictive biomarker for therapeutic efficacy, which was validated in different independent patient cohorts.ConclusionThe present study provides a new understanding of macrophage heterogeneity and its association with OV prognosis and underlines the future clinical potential of a macrophage activation model for tumor prevention and treatment.Graphical abstractDownload : Download high-res image (64KB)Download : Download full-size image

multidisciplinary sciences
The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer

Marek Nowak,Magdalena Klink

DOI: https://doi.org/10.3390/cells9051299

IF: 6

2020-05-22

Cells

Abstract:Tumor-associated macrophages (TAMs) constitute the main population of immune cells present in the ovarian tumor microenvironment. These cells are characterized by high plasticity and can be easily polarized by colony-stimulating factor-1, which is released by tumor cells, into an immunosuppressive M2-like phenotype. These cells are strongly implicated in both the progression and chemoresistance of ovarian cancer. The main pro-tumoral function of M2-like TAMs is the secretion of a variety of cytokines, chemokines, enzymes and exosomes that reach microRNAs, directly inducing the invasion potential and chemoresistance of ovarian cancer cells by triggering their pro-survival signaling pathways. The M2-like TAMs are also important players in the metastasis of ovarian cancer cells in the peritoneum through their assistance in spheroid formation and attachment of cancer cells to the metastatic area—the omentum. Moreover, TAMs interplay with other immune cells, such as lymphocytes, natural killer cells, and dendritic cells, to inhibit their responsiveness, resulting in the development of immunosuppression. The detrimental character of the M2-like type of TAMs in ovarian tumors has been confirmed by a number of studies, demonstrating the positive correlation between their high level in tumors and low overall survival of patients.

cell biology
Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis

Xia Yuan,Jing Zhang,Dan Li,Ye Mao,Fei Mo,Wei Du,Xuelei Ma

DOI: https://doi.org/10.1016/j.ygyno.2017.07.007

IF: 5.304

2017-01-01

Gynecologic Oncology

Abstract:•Higher M1/M2 TAMs ratio in ovarian tumors was associated with a favorable OS and PFS.•High density of CD163+ TAMs might predict poor prognosis in patients with ovarian cancer.•M1 and M2 subsets presented distinct effects on ovarian cancer prognosis.•This suggests that M2 subtypes could be a potential therapeutic target of ovarian cancer.•High density of TAMs was related to advanced TNM stage of ovarian cancer.
Effect of Macrophages on the Expression of Vascular Cell Adhesion Molecule 1 in Ovarian Carcinoma Cells and Its Mechanism

Zhou Ru,Feng Qian,Yu Shentong,Yang Tong,Yu Shuhong,Liu Shuang,Cui Zhuqing,Zhang Jing

DOI: https://doi.org/10.3760/cma.j.issn.1006-9801.2018.10.001

2018-01-01

Abstract:Objective To explore the effect of macrophages on the expression of vascular cell adhesion molecule 1 (VCAM1) in ovarian carcinoma cells and its mechanism. Methods Phorbol ester and lipopolysaccharide were used to activate the monocyte THP-1 that would become macrophages . Enzyme linked immunosorbent assay (ELISA) was used to detect the cytokines level in the supernatant of macrophages. The effect of macrophages ' supernatant on VCAM1 mRNA expression of ovarian HEY and IGROV1 carcinoma cells was detected by using quantitative real-time and polymerase chain reaction (qRT-PCR). Western blot was used to detect the effect of macrophages ' supernatant on VCAM1 protein expression of ovarian carcinoma cells with VCAM1 over expression (HEY-VCAM1 and IGROV1-VCAM1). Dual-luciferase report gene assay was used to detect the effect of macrophages' supernatant and the cytokines on promoter transcriptional activity in different truncations of human embryonic kidney cells HEK293T VCAM1 gene. Results Compared with the supernatant of THP-1 cells, the release number of tumor necrosis factor α (TNF-α), interleukin (IL)-6 and IL-12 in supernatant from macrophages was increased (all P< 0.05), and IL-10 was decreased (t=3.841, P=0.019). The levels of VCAM1 mRNA in HEY and IGROV1 cells were upregulated by macrophages' supernatant and 1 ng/ml TNF-α, and macrophages' supernatant could promote the expression levels of VCAM1 protein in HEY-VCAM1 cells and IGROV1-VCAM1 cells. Compared with the empty vector (pGV354) control group [(8.6 ±0.2) ×10-3 relative light unit (RLU)], the reporter gene luciferase activity of human embryonic kidney cells HEK293T VCAM1 gene promoter region were upregulated by supernatant from macrophages located at -1641 bp to +12 bp including the transcription binding site of AP-1 [(109.4±3.4)×10-3 RLU], and there was a significant difference (t=29.42, P<0.001). Compared with the negative control group untreated by cytokine [(21.0 ±0.5) ×10-3 RLU], 100 ng/ml TNF-α could promote the transcriptional activity of -1641 bp to +12 bp promoter of VCAM1 in HEK293T cells [(23.4±0.4)×10-3 RLU;t=4.134, P=0.001]. 150 ng/ml IL-6 had no effect on the transcriptional activity of the promoter [(21.4±1.0)× 10-3 RLU; t= 0.328, P= 0.708]. 5 ng/ml IL-12 inhibited the transcriptional activity of the promoter [(14.3 ± 1.0)×10-3 RLU;t= 6.390, P< 0.001]. Conclusion Macrophages can promote VCAM1 expression in ovarian carcinoma cells by secreting inflammatory factors like TNF-α to affect VCAM1 promoter region containing AP1 transcription binding site and can promote VCAM1 mRNA expression in ovarian cancer cells.
Tumor-associated Macrophages Promote Invasion Via Toll-like Receptors Signaling in Patients with Ovarian Cancer

Xing Ke,Shuping Zhang,Meng Wu,Jianfang Lou,Jiexin Zhang,Ting Xu,Lei Huang,Peijun Huang,Fang Wang,Shiyang Pan

DOI: https://doi.org/10.1016/j.intimp.2016.08.029

IF: 5.714

2016-01-01

International Immunopharmacology

Abstract:Tumor-associated macrophages (TAMs) derived from peripheral blood monocytes recruit into tumor microenvironment and display functions associated with tumor progression. The mechanisms by which TAMs display roles that associated with the invasion ability of ovarian cancer have not been well investigated. In our research, we found abundant TAMs infiltrate in ovarian cancer compared with benign ovarian tumor tissues. Levels of matrix metalloproteinase (MMP)-2, MMP-9 and MMP-10, and Toll-like receptors (TLRs) signaling proteins were evaluated in ovarian cancer. The high level of TAMs was associated with metastasis and advance of patients with ovarian cancer. TAMs and ovarian cancer cell line SKOV3 were cocultured in vitro, MMPs level and the invasion ability of SKOV3 cells were significantly up-regulated. The coculture process was correlated with the activation of TLRs signaling and downstream nuclear factor (NF)-κB p65 and microtubule-associated proteins (MAPs) kinases pathway in SKOV3. In addition, pre-incubation with TLRs signaling inhibitors remarkably suppressed invasion ability of SKOV3. Levels of TLRs signaling pathways proteins were also down-regulated in this blocking process. These findings demonstrated that TAMs promoted up-regulation of MMP-2, MMP-9 and MMP-10 expressions and enhanced ovarian cancer cells invasion via TLRs signaling pathway. We conclude that TAMs could enhance ovarian cancer cells invasion and ultimately promote ovarian cancer progression.
Progress in the Research of Tumor Therapy Aimed at Tumor Associated Macrophages

ZHANG Yuan,WANG Yue

DOI: https://doi.org/10.3760/cma.j.issn.1673-4394.2010.02.005

2010-01-01

International Journal of Immunology

Abstract:Although tumors are capable of autonomous growth,their proliferation is highly influenced by their microenvimnment.Tumor-associated macmphages(TAM)are a major pro-proliferation factor for tumors and they decide the final outcome of tumor-bearing of individuals.Recently,macmphages have been characterized as having M1 or M2 phenotype based on receptor expression.cytokine and effector molecule production and function.TAM generally has an M2 phenotype.This review focuses on altering the type of macrophages and in order to induce them to the direction of anti-tumor immunity.This approach may represent a norel therapeutic strategy against cancer.
Research progress and clinical applications of tumor associated macrophage

Jiani LI,Zhuo WANG,Rui SUN,Yong YANG

DOI: https://doi.org/10.13506/j.cnki.jpr.2016.04.014

2016-01-01

Abstract:Macrophage which surrounds tumor cells is termed tumor associated macrophage(TAM). TAM takes part in tumor initiation,invasion,metastasis and suppression of anti - tumor immune response. The amount of TAM,to a certain de-gree,can predict the prognosis of cancer patients. So far,some new medicine had been used in clinical treatment targeting TAM.
Tumor‐associated macrophage‐targeted therapeutics in ovarian cancer

Yuanyuan An,Qing Yang

DOI: https://doi.org/10.1002/ijc.33408

2020-12-04

International Journal of Cancer

Abstract:Ovarian cancer is one of the most common gynecological malignancies. The tumor microenvironment plays an important role in regulating the progression of ovarian cancer. Macrophages, which are important immune cells in the tumor microenvironment, participate in the regulation of various biological behaviors and influence the prognosis of ovarian cancer. A large number of studies have targeted macrophages for the treatment of ovarian cancer. In addition, macrophages also play a regulatory role by interacting with other immune cells, including T cells and mesothelial cells, in the ovarian cancer microenvironment. In this review, we discuss the progress made in macrophage targeted therapy for ovarian cancer. Although there are still several challenges in using this treatment, targeted macrophage therapy is still a promising treatment for ovarian cancer.This article is protected by copyright. All rights reserved.

oncology
Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer

Emily K. Colvin

DOI: https://doi.org/10.3389/fonc.2014.00137

IF: 4.7

2014-06-06

Frontiers in Oncology

Abstract:Ovarian cancer is the leading cause of death in women with gynecological malignancy and improvements in current treatments are needed. As with many other solid cancers, the ovarian tumor microenvironment is emerging as a key player in tumor progression and a potential therapeutic target. The tumor microenvironment contains several non-malignant cell types that are known to contribute to tumor progression and metastasis. Included in this population of non-malignant cells are several different types of immune cells, of which tumor-associated macrophages (TAMs) are the most abundant. An increasing amount of evidence is emerging to suggest that TAMs display a unique activation profile in ovarian tumors and are able to create an immunosuppressive microenvironment, allowing tumors to evade immune detection and promoting tumor progression. Therefore, an increased understanding of how these immune cells interact with tumor cells and the microenvironment will greatly benefit the development of more effective immunotherapies to treat ovarian cancer. This review focuses on the role of TAMs in the ovarian tumor microenvironment and how they promote tumor progression.

oncology
Tumor associated macrophages (TAMs): from mechanisms to therapeutic implications

LUO Congzhou,LIU Yujia,CHEN Jun

DOI: https://doi.org/10.3969/j.issn.1000-484X.2023.03.001

2023-01-01

Abstract:Macrophages are important components of the tumor microenvironment（TME） and are critical for tumor development. The immune system maintains immune surveillance of precancerous mutant cells to suppress tumor development, where macrophages play indispensable functions. However, there are abundant evidences demonstrating that tumor-associated macrophages（TAMs） undergo functional transition during cancer progression and become immunosuppressive in favor of tumor progression. The mechanisms of the functional transition of TAMs have been investigated by different approaches, and these mechanisms have been used to explore novel strategies for cancer immunotherapy targeting TAMs. In this paper, we will describe the evolution of macrophage classification methods and present new advances in cancer immunotherapy targeting TAMs with clinical information.
Study on immunoadhesins for IL-10 and tumor associated macrophages on the invasion of ovarian cancer

李乔,尹如铁,周乐,高倩,牛艺臻

DOI: https://doi.org/10.13375/j.cnki.wcjps.2017.03.011

2017-01-01

Abstract:OBJECTIVE To investigate the effect of immunoadhesin for IL-10 and tumor associated macrophages (TAM) on the invasion of ovarian cancer cells and the relationship between immunoadhesin for IL-10 and TAM.METHODS By stimulating THP-1 to differentiate into macrophages,which was used to imitate intracorporal TAM.The culture medium was collected to get TAM conditioned medium.The ES-2 cells were then treated with conditioned medium.The effect of TAM on the invasion of ES-2 cells was determined by matrigel invasion assay to observe the number of cells passing through the transwell chamber.The change of HIF-1α in ES-2 cells treated with TAM was detected by Western blot.Besides,the effect of IL-10 antagonist on the level of HIF-1α protein and invasiveness of ES-2 cells was observed.RESULTS The invasiveness of ES-2 cells was significantly higher than that of the normal medium (P ＜ 0.05).The level of HIF-1 α protein in ES-2 cells was also significantly higher than that in normal medium (P ＜ 0.05).The level of HIF-1 α protein and cell invasiveness in ES-2 were significantly decreased after treatment with IL-10 antagonist(P ＜ 0.05).CONCLUSION TAM may up-regulate the level of IL-10,induce the elevation of HIF-1α protein in ovarian cancer cells,and promote the invasion and metastasis of ovarian cancer cells.This has laid a certain experimental basis for targeting/immunotherapy of ovarian cancer.
Mixed-phenotype of tumor-associated macrophages in the peritoneal environment of ovarian cancer and its TLR expression characteristics

Hui FENG,Jing TIAN,Hexi SUN,Shanling ZhANG,Baohui JU,Quan HAO

DOI: https://doi.org/10.3969/j.issn.1000-8179.2013.07.002

2013-01-01

Chinese Journal of Clinical Oncology

Abstract:Objective:This study investigates the following:proportions of tumor-associated macrophage(TAM) and its subpopulations in the ascite of ovarian cancer(OC) patients and expression of mammalian homologs of the toll-like receptors(TLRs) in different TAM subpopulations.Methods:CD68+TAM expression was detected by streptavidin-peroxidase immunohistochemical staining.Proportions of TAM and its subpopulations were identified by flow cytometry.RNA assessment of TLR was performed by real-time polymerase chain reaction.Results:Mean density of CD68+TAM was similar between OC patients and those with benign tumor(73.6 vs.50.2 per vision field,P>0.05).CD68+ TAM in the ascite exhibited no difference between OC patients and those with benign tumor(P>0.05).However,M1 macrophage in OC ascites was significantly less than those found in benign tumor(30.5% vs.53.3%;P<0.01).M2 macrophage in OC ascites was significantly higher than those found in benign tumor(54.3% vs.10.1%;P<0.05).TLR level was similar in M1 and M2 macrophages(P>0.05).Conclusion:A mixed-phenotype of tumor-associated macrophages was found in the peritoneal environment.M2 macrophages were dominant in the ascite of OC,whereas M1 macrophages were predominant in the benign tumor.TLRs were not the key factors that affected the polarization of macrophages.

Effect of macrophages on biological function of ovarian cancer cells in tumor microenvironment in vitro

Ott_a_216355 8687..8699

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction

Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients

Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy

[Effect of Antibacterial Peptide Hcap18/ll-37 on Ovarian Cancer Microenvironment and the Regulatory Mechanism of Its Expression].

Tumor-Associated Macrophages (tams): A Critical Activator in Ovarian Cancer Metastasis

Prognostic Significance of Tumor-Associated Macrophages in Ovarian Cancer: A Meta-Analysis.

Integrated immunogenomic analysis of single-cell and bulk tissue transcriptome profiling unravels a macrophage activation paradigm associated with immunologically and clinically distinct behaviors in ovarian cancer

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer

Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis

Effect of Macrophages on the Expression of Vascular Cell Adhesion Molecule 1 in Ovarian Carcinoma Cells and Its Mechanism

Tumor-associated Macrophages Promote Invasion Via Toll-like Receptors Signaling in Patients with Ovarian Cancer

Progress in the Research of Tumor Therapy Aimed at Tumor Associated Macrophages

Research progress and clinical applications of tumor associated macrophage

Tumor‐associated macrophage‐targeted therapeutics in ovarian cancer

Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer

Tumor associated macrophages (TAMs): from mechanisms to therapeutic implications

Study on immunoadhesins for IL-10 and tumor associated macrophages on the invasion of ovarian cancer

Mixed-phenotype of tumor-associated macrophages in the peritoneal environment of ovarian cancer and its TLR expression characteristics